For HIV-coinfected individuals, gbp5 diagnostic performance improves under immunodeficiency (AUC: From 0.74 to 0.86), while the gbp5, dusp3, and klf2 combination maintains specificity via stable epigenetic modifications, offering an adapted solution for this high-risk group [23,28]. This evidence concerns the gene GBP5 and immunodeficiency disease.